TRASYLOL
LOE ApproachingBLAINJECTIONINJECTABLEPriority Review
Approved
Dec 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 5h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TRASYLOL is a biologic injectable approved in 1993 for an undisclosed indication. The product mechanism of action and pharmacologic class are not publicly detailed in available data. This appears to be an established biologic with significant commercial history and approaching loss of exclusivity.
LOE Approaching
Product is in late-stage commercial lifecycle with approaching loss of exclusivity, suggesting smaller and strategically focused team operations focused on managed decline and lifecycle extension initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Aprotinin US Special Access Protocol
Postoperative Hemorrhage
Career Relevance
TRASYLOL currently shows zero linked job openings, reflecting its LOE-approaching status and reduced hiring activity. Career opportunities on this product are limited and focused on lifecycle management, retention strategies, and managing competitive erosion rather than growth initiatives.
Brand Manager
Worked on TRASYLOL at Bayer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.